Literature DB >> 31061834

Intermittent Intraputamenal Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease: Seeking the Path to Neurorestoration.

Nicholas Cothros1, Alex Medina1, Veronica Bruno1.   

Abstract

Entities:  

Keywords:  Parkinson's disease; clinical trial; glial cell line–derived neurotrophic factor (GDNF); intraputamenal infusion

Year:  2019        PMID： 31061834      PMCID： PMC6476594          DOI： 10.1002/mdc3.12757

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  5 in total

1.  GDNF enhances the synaptic efficacy of dopaminergic neurons in culture.

Authors:  M J Bourque; L E Trudeau
Journal:  Eur J Neurosci       Date:  2000-09       Impact factor: 3.386

2.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

Authors:  L F Lin; D H Doherty; J D Lile; S Bektesh; F Collins
Journal:  Science       Date:  1993-05-21       Impact factor: 47.728

3.  Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.

Authors:  Anthony E Lang; Steven Gill; Nik K Patel; Andres Lozano; John G Nutt; Richard Penn; David J Brooks; Gary Hotton; Elena Moro; Peter Heywood; Matthew A Brodsky; Kim Burchiel; Patrick Kelly; Arif Dalvi; Burton Scott; Mark Stacy; Dennis Turner; V G Frederich Wooten; William J Elias; Edward R Laws; Vijay Dhawan; A Jon Stoessl; James Matcham; Robert J Coffey; Michael Traub
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

4.  Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease.

Authors:  Anna-Maija Penttinen; Ilmari Parkkinen; Merja H Voutilainen; Maryna Koskela; Susanne Bäck; Anna Their; Christopher T Richie; Andrii Domanskyi; Brandon K Harvey; Raimo K Tuominen; Liina Nevalaita; Mart Saarma; Mikko Airavaara
Journal:  Front Neurol       Date:  2018-06-20       Impact factor: 4.003

5.  Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease.

Authors:  Alan Whone; Matthias Luz; Mihaela Boca; Max Woolley; Lucy Mooney; Sonali Dharia; Jack Broadfoot; David Cronin; Christian Schroers; Neil U Barua; Lara Longpre; C Lynn Barclay; Chris Boiko; Greg A Johnson; H Christian Fibiger; Rob Harrison; Owen Lewis; Gemma Pritchard; Mike Howell; Charlie Irving; David Johnson; Suk Kinch; Christopher Marshall; Andrew D Lawrence; Stephan Blinder; Vesna Sossi; A Jon Stoessl; Paul Skinner; Erich Mohr; Steven S Gill
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501
  5 in total
  1 in total

1.  Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson's Disease. A Systematic Review.

Authors:  Piniel Alphayo Kambey; Kouminin Kanwore; Abiola Abdulrahman Ayanlaja; Iqra Nadeem; YinZhen Du; Wokuheleza Buberwa; WenYa Liu; Dianshuai Gao
Journal:  Front Aging Neurosci       Date:  2021-02-24       Impact factor: 5.750
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.